| Trial ID: | L1410 |
| Source ID: | NCT05601271
|
| Associated Drug: |
Allopurinol
|
| Title: |
Effect of Allopurinol on Markers of Mineral and Bone Metabolism
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Diseases|Osteodystrophy|Uric Acid Concentration, Serum, Quantitative Trait Locus 7
|
| Interventions: |
DRUG: Allopurinol
|
| Outcome Measures: |
Primary: 1,25 dihydroxivitamin D, Increase in 1,25 dihydroxivitamin D, 3 months|FGF-23, Reduction of FGF-23, 3 months|Klotho, Increase in alpha Klotho, 3 months |
|
| Sponsor/Collaborators: |
Sponsor: University of Sao Paulo General Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2021-03-01
|
| Completion Date: |
2025-03-01
|
| Results First Posted: |
|
| Last Update Posted: |
2025-04-02
|
| Locations: |
Hospital das Clinicas HCFMUSP, São Paulo, SP, 05403000, Brazil
|
| URL: |
https://clinicaltrials.gov/show/NCT05601271
|
